Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM

Author:

Kriegsmann Katharina1,Manta Calin1,Schwab Ricarda1,Mai Elias K.1ORCID,Raab Marc S.1,Salwender Hans J.2,Fenk Roland3,Besemer Britta4,Dürig Jan5ORCID,Schroers Roland6ORCID,von Metzler Ivana7,Hänel Mathias8,Mann Christoph9ORCID,Asemissen Anne M.10,Heilmeier Bernhard11,Bertsch Uta112,Huhn Stefanie1,Müller-Tidow Carsten1ORCID,Goldschmidt Hartmut112ORCID,Hundemer Michael113

Affiliation:

1. 1Department of Hematology, Oncology, and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany

2. 2Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany

3. 3Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany

4. 4Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany

5. 5Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany

6. 6Department of Hematology and Oncology, Ruhr-University Bochum, Bochum, Germany

7. 7Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany

8. 8Department of Internal Medicine III, Clinic Chemnitz, Chemnitz, Germany

9. 9Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany

10. 10Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

11. 11Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany

12. 12National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany

13. 13Medizinisches Versorgungszentrum am Kreiskrankenhaus Bergstraße gGmbH, Heppenheim, Germany

Publisher

American Society of Hematology

Subject

Hematology

Reference19 articles.

1. A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma;Munshi;Blood Adv,2020

2. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016

3. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing;Rasche;Nat Commun,2017

4. Molecular detection of minimal residual disease in multiple myeloma;Bai;Br J Haematol,2018

5. Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease;Waldschmidt;Semin Hematol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3